BioMOBIUS™ Research Platform Allows Sophisticated Technology Solutions for Biomedical Research

TRIL (Technology Research for Independent Living) CentreTRIL (Technology Research for Independent Living) Centre launched the BioMOBIUS™ Research Platform, an open shareable technology platform, which allows researcher to rapidly develop sophisticated technology solutions for biomedical research. This platform helps researchers to reduce the time spent on developing foundational technologies, allowing them to focus on their actual research.

The software elements of BioMOBIUS™ provide:

  • Rapid Development (Graphical Development Environment)
  • Biosignal Processing Applications (Real Time)
  • Mobile hardware and physiological sensor support
  • Straightforward user interfaces (GUI Designer)
  • Reduced Development Replication (Re-use of Blocks)
  • Targeting applications

The BioMOBIUS Research Platform was developed by the TRIL Centre, a groundbreaking research collaboration between Intel Corporation and a number of Irish academic partners, and jointly funded by Intel and the Industrial Development Agency (IDA) Ireland. Its goal is to explore technology to help older people to continue living independently. The platform is being used primarily by TRIL researchers to help clinicians detect and prevent or alleviate certain conditions related to ageing, such as falls and cognitive decline, and to help older people to strengthen their social connections.

The hardware elements of the BioMOBIUS™ research platform provide support for the SHIMMER wireless sensor platform and other third party hardware and sensor devices.

BioMOBIUS™ is freely available to users for research purposes only. Please follow the links to the register and download pages to obtain a copy of the BioMOBIUS™ software environment. Details on hardware support and availability can be found in the hardware section. Please feel to share your experiences of MOBIUS and suggestions for enhancements and new features via the provided discussion forum.

For further information, please visit:
http://biomobius.trilcentre.org

Related news articles:

About the TRIL Centre
The TRIL Centre is a multi-million euro research collaboration between industry and academic partners including Intel, University College Dublin, Trinity College Dublin and the National University of Ireland, Galway. The Centre has created dedicated laboratories at Intel and in each of the universities involved, and is driving bi-directional knowledge and technology transfer of research that addresses the physical, cognitive and social consequences of ageing. The TRIL Centre is one of the largest research projects of its kind in the world. It will develop innovative technologies to help people 'age in place' wherever they choose to live. For more information, please visit www.trilcentre.org.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...